These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 17373782)
1. D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistance. Wang J; Jin Y; Rapp KL; Schinazi RF; Chu CK J Med Chem; 2007 Apr; 50(8):1828-39. PubMed ID: 17373782 [TBL] [Abstract][Full Text] [Related]
2. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance. Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiviral activity, and mechanism of drug resistance of D- and L-2',3'-didehydro-2',3'-dideoxy-2'-fluorocarbocyclic nucleosides. Wang J; Jin Y; Rapp KL; Bennett M; Schinazi RF; Chu CK J Med Chem; 2005 Jun; 48(11):3736-48. PubMed ID: 15916425 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, anti-HIV activity, and molecular mechanism of drug resistance of L-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides. Choo H; Chong Y; Choi Y; Mathew J; Schinazi RF; Chu CK J Med Chem; 2003 Jan; 46(3):389-98. PubMed ID: 12540238 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure-activity relationships, and mechanism of drug resistance of D- and L-beta-3'-fluoro-2',3'-unsaturated-4'-thionucleosides as anti-HIV agents. Zhu W; Chong Y; Choo H; Mathews J; Schinazi RF; Chu CK J Med Chem; 2004 Mar; 47(7):1631-40. PubMed ID: 15027854 [TBL] [Abstract][Full Text] [Related]
6. Stereoselective synthesis and antiviral activity of D-2',3'-didehydro-2',3'-dideoxy-2'-fluoro-4'-thionucleosides. Chong Y; Choo H; Choi Y; Mathew J; Schinazi RF; Chu CK J Med Chem; 2002 Oct; 45(22):4888-98. PubMed ID: 12383014 [TBL] [Abstract][Full Text] [Related]
7. The role of 2',3'-unsaturation on the antiviral activity of anti-HIV nucleosides against 3TC-resistant mutant (M184V). Choo H; Chong Y; Chu CK Bioorg Med Chem Lett; 2003 Jun; 13(12):1993-6. PubMed ID: 12781181 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, structure-activity relationships, and drug resistance of beta-d-3'-fluoro-2',3'-unsaturated nucleosides as anti-HIV Agents. Zhou W; Gumina G; Chong Y; Wang J; Schinazi RF; Chu CK J Med Chem; 2004 Jun; 47(13):3399-408. PubMed ID: 15189036 [TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of 2'-fluoro-2',3'-unsaturated D-nucleosides as anti-HIV-1 agents. Lee K; Choi Y; Gumina G; Zhou W; Schinazi RF; Chu CK J Med Chem; 2002 Mar; 45(6):1313-20. PubMed ID: 11882000 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase. Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683 [TBL] [Abstract][Full Text] [Related]
12. Stereoselective synthesis of D- and L-carbocyclic nucleosides by enzymatically catalyzed kinetic resolution. Mahler M; Reichardt B; Hartjen P; van Lunzen J; Meier C Chemistry; 2012 Aug; 18(35):11046-62. PubMed ID: 22829408 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activities of unsymmetrical long chain dicarboxylate esters of dinucleoside reverse transcriptase inhibitors. Agarwal HK; Chhikara BS; Doncel GF; Parang K Bioorg Med Chem Lett; 2017 May; 27(9):1934-1937. PubMed ID: 28351588 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor. Boojamra CG; Mackman RL; Markevitch DY; Prasad V; Ray AS; Douglas J; Grant D; Kim CU; Cihlar T Bioorg Med Chem Lett; 2008 Feb; 18(3):1120-3. PubMed ID: 18164198 [TBL] [Abstract][Full Text] [Related]
15. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure. Miller V; Larder BA Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471 [TBL] [Abstract][Full Text] [Related]